Hypertension is the most important chronic health problem. It is estimated that hypertension
affects approximately one billion people and that this number will increase by 60% until the …

Hypertension, which is pointed to be the most frequent cause of death in the World and in
Turkey and defined by the World Health Organization as global health crisis and the …

Hypertension is a multifactorial medical condition which essentially described as persistently
high blood pressure exceeding the normal range of blood pressure which is set at systolic …

Objective This study was designed mainly to establish the rates of response to valsartan 80
mg once daily (qd) and to valsartan 160 mg qd given to non-responders to 80 mg qd, as well …

Valsartan is a highly selective, orally available antagonist of the angiotensin Type 1 (AT1)
receptor. It is indicated for treatment of mild to moderate essential hypertension …

Valsartan is a specific angiotensin II receptor antagonist with high selectivity for the AT 1
receptor subtype. After oral administration of single or repeated once-daily doses, valsartan …

Valsartan is a widely used, efficacious and very well-tolerated antihypertensive agent. By
specifically blocking the action of angiotensin II on the angiotensin Type 1 receptor …

Objective: To study the efficacy and tolerability of a range of valsartan doses in patients with
mild-to-moderate hypertension. Design: 122 adult out-patients were randomised in equal …

Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …

Objective. To evaluate the efficacy and safety of valsartan in Taiwanese patients with
essential hypertension. Methods. This 12-week multi-center, open-label, observational, post …